Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues

Cancer Research - United States
doi 10.1158/0008-5472.can-05-4300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

DNA Sequence Context as a Marker of CpG Methylation Instability in Normal and Cancer Tissues

Scientific Reports
Multidisciplinary
2020English

Immunohistochemistry as Surrogate Marker for Molecular Typing of Special Types of Breast Carcinomas

Journal of Evidence Based Medicine and Healthcare
2016English

Allele Imbalance or Loss of Heterozygosity in Normal-Appearing Breast Epithelium as a Novel Marker to Predict Future Breast Cancer

2007English

High Expression of EZH2 as a Marker for the Differential Diagnosis of Malignant and Benign Myogenic Tumors

Scientific Reports
Multidisciplinary
2018English

Expression of Stemness Genes in Primary Breast Cancer Tissues: The Role of SOX2 as a Prognostic Marker for Detection of Early Recurrence

Oncotarget
Oncology
2014English

Multiphoton Microscopy of Endogenous Fluorescence Differentiates Normal, Precancerous, and Cancerous Squamous Epithelial Tissues

Cancer Research
Cancer ResearchOncology
2005English

P33ING1b Methylation in Fecal DNA as a Molecular Screening Tool for Colorectal Cancer and Precancerous Lesions

Oncology Letters
Cancer ResearchOncology
2014English

EZH2 Is a Sensitive Marker of Malignancy in Salivary Gland Tumors

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy